Track the Q32 Bio Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €474.8m. The latest transaction was disclosed on 20 July 2026 (Attribution). Among the most active insiders: Violette Shelia M.. All data is openly available.
25
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€193,288
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Q32 Bio Inc. Strong Buy (bullish), based on 4 analysts. Average price target: US$42.75.
56Σ signal
Buys n/a€193,288 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,640 of 28,832 companies
67.1
score / 100
Value
42
Quality
92
FCF yld-7.1%
Earn yld6.3%
EV/EBITDA15.7x
ROE72%
Gross mgn·
Net mgn55%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Q32 Bio Inc. is a biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory diseases. It is listed on NASDAQ under the ticker Q32.